Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case - Reuters
Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxOQVJOTDNRQmlvcHhPQmpONUZzeEFjaWVtaS1STU9FczRqTE4tZGhYWXBzSmttLUNtXzlxMnhPTUpmd0ZVdF8taFBVVFZWVGxjSEg5dGZRYW1DeVVPRkRReExKdC1SQlRIREJWamtCMk5ZUzIydkI5NkJFc2R1UzRTaVExdlp1ZzRpeWgtSXhveWJyUHVONmlUc0pSYXJwMUk5YnotVzVCTWpVWXU3a0JxdW1vQWNaLTQtSFhsd3pzc0xaNzdLRW5hbkhR?oc=5" target="_blank">Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui - Reuters
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui Reuters
September 29, 2026 at 04:47 AMRegeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - reuters.com
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial reuters.com
September 30, 2026 at 10:30 PMUS FDA extends review of Novo Nordisk's hemophilia drug over facility issues - Reuters
US FDA extends review of Novo Nordisk's hemophilia drug over facility issues Reuters
October 2, 2026 at 09:52 PMPatients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study - Reuters
Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study Reuters
September 30, 2026 at 09:57 AMLilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com
Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com
September 29, 2026 at 10:15 PMUS states filed fraud lawsuit over Corteva's Vylor spinoff - Reuters
US states filed fraud lawsuit over Corteva's Vylor spinoff Reuters
October 1, 2026 at 06:52 PM